CELH

Celsius Holdings, Inc. 10-Q Summary: Q2 2025

Business Context and Reporting Period

This report covers the quarterly period ended June 30, 2025. Celsius Holdings, Inc. operates as a single reporting segment focused on functional energy and wellness beverages. The period was defined by the strategic acquisition of Alani Nutrition LLC ("Alani Nu") on April 1, 2025, which expanded the company's portfolio into adjacent wellness categories. The company maintains a long-term distribution partnership with PepsiCo Inc. in the U.S. and Canada.

Key Financial Metrics

Material Changes vs. Prior Period

• Revenue Growth: Q2 2025 revenue increased 83.9% year-over-year, driven primarily by the inclusion of Alani Nu, which contributed approximately $301.2 million in revenue for the quarter. North American revenue grew 86.9%.
• Expense Expansion: Selling, General, and Administrative (SG&A) expenses rose 107.1% in Q2 to $237.9 million. Increases were attributed to Alani Nu integration costs ($29.7M marketing, $15.8M admin), the "Live. Fit. Go." marketing campaign ($17.5M), and a $13.8M remeasurement of contingent consideration for the Alani Nu acquisition.
• Debt Incurrence: The company incurred $900 million in term loan debt in April 2025 to fund the Alani Nu acquisition. This resulted in $18.1 million of interest expense in Q2 2025, compared to zero in the prior year.
• Balance Sheet Impact: Total assets increased from $1.77 billion to $3.80 billion, largely due to the recognition of $1.1 billion in indefinite-lived brand intangibles and $802 million in goodwill from the Alani Nu acquisition.

Outlook, Risks, and Unusual Items

• Acquisition Integration: Management expects continued investment in Alani Nu's commercial expansion. The company is currently evaluating the impact of the "One Big Beautiful Bill Act" (signed July 4, 2025) on its tax regime, though no impact is reflected in Q2 results.
• Legal Contingencies:
  • Strong Arm Productions: A jury verdict of $82.6 million was vacated by the Florida Fourth District Court of Appeal, directing a retrial on damages. The company has accrued $56.9 million (the low end of a $56.9M–$99.3M estimated range) for this liability.
  • SEC Settlement: A $3.0 million civil penalty was paid in Q1 2025 to settle an SEC inquiry regarding internal controls; the investigation is concluded.
  • Securities Litigation: Putative class actions regarding the PepsiCo distribution agreement remain pending, with the company filing a motion to dismiss in June 2025.
• Tariffs: The company notes that while tariffs have increased certain costs, the aggregate impact was not a key driver of cost of revenue in Q2. Future quarters may see greater impact.
• Contingent Consideration: The liability for the Alani Nu acquisition was remeasured to the maximum $25.0 million payout due to strong revenue performance, resulting in a $13.8 million non-cash expense.

Investor Verification Checklist

• Verify the final purchase price allocation for the Alani Nu acquisition, as the company is still in the measurement period for intangible asset valuations.
• Monitor the outcome of the retrial regarding the Strong Arm Productions lawsuit, as the final liability could range up to $99.3 million.
• Assess the impact of the new $900 million term loan on future interest coverage ratios and cash flow, given the variable interest rate structure.
• Review the integration progress of Alani Nu to ensure projected synergies and revenue targets are met, which triggers the full $25 million contingent payment.
• Track the status of pending securities class actions related to the PepsiCo distribution agreement.